Jupiter, FL, United States of America

Daisy J Li

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Santolecan Pharmaceuticals LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daisy J Li. Retrieved from https://idiyas.com/inventor/daisy-j-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Daisy J Li

Introduction

Daisy J Li is an accomplished inventor based in Jupiter, FL (US). She has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. Her innovative work has led to the development of unique compounds that have the potential to enhance therapeutic efficacy.

Latest Patents

Daisy holds a patent for "Taxane-lipid-polysaccharide dual conjugates, preparation methods thereof and uses thereof." This invention pertains to a group of taxane-lipid-polysaccharide dual conjugates, a process for their preparation, and their applications in pharmaceutical compositions. The invention also includes a series of intermediates for the preparation of these dual conjugates, which can serve as effective drug delivery vehicles. She has 1 patent to her name.

Career Highlights

Daisy is currently associated with Santolecan Pharmaceuticals LLC, where she continues to push the boundaries of pharmaceutical innovation. Her work focuses on creating advanced drug delivery systems that can improve patient outcomes.

Collaborations

Daisy collaborates with talented individuals in her field, including Jinghua Hu and Xiaohai Li. These partnerships enhance her research and development efforts, leading to groundbreaking advancements in pharmaceutical technology.

Conclusion

Daisy J Li is a notable inventor whose work in drug delivery systems exemplifies innovation in the pharmaceutical industry. Her contributions are paving the way for more effective treatments and improved patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…